DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)

NCT07070440 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: DZD6008
DRUG: Pemetrexed
DRUG: Carboplatin
DRUG: Docetaxel

Sponsor

Dizal Pharmaceuticals